Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine in decompensated heart failure
NCT03701880Unknown
- Sponsor
- Ain Shams University
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ivabradine in heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by Ain Shams University. Primary endpoint: Serum Pro-BNP level at 3 months. Status: unknown.
02
Drugs
ivabradine
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT03701880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701880.